ALBUQUERQUE, NM -- (MARKET WIRE) -- July 21, 2006 -- Exagen Diagnostics, Inc., which develops and commercializes genomic marker-based in vitro diagnostic (IVD) kits for predicting risk of recurrence or treatment response, today announced that it has created an executive committee from their senior management team and named Dana Scofield, CPA, as controller.
